Please contribute to the selection of the American College of Toxicology (ACT) President’s Award for the Best Paper published in International Journal of Toxicology. The winner is selected by the Publications Committee with input from members of ACT. Papers eligible for the award are those that were published in Issue 5 and 6 of the previous volume (2013), as well as Issues 1–4 of 2014. While there is a formal process for the nomination of a paper (see Best Paper Award), I would be delighted to receive your nominations via a quick email message if that is more convenient for you.
To nominate, just mention the paper and provide a brief rationale as to why you believe your nomination deserves this recognition. The winner will be announced at the ACT Annual Meeting Awards Luncheon. I look forward to hearing from you by September 10 with your nomination. I assure you that the Publications Committee will take your suggestions seriously.
Citations for the five most recent winning papers follow:
- 2009: Bussiere JL, et al. Alternative strategies for toxicity testing of species-specific biopharmaceuticals. Int J Toxicol. 2009 28(3):230-53.
- 2010: Battaglia CL, et al. Malathion, lindane, and piperonyl butoxide, individually or in combined mixtures, induce immunotoxicity via apoptosis in murine splenocytes in vitro. Int J Toxicol. 2010 29(2):209-20.
- 2011: Bugelski PJ, et al. Critical review of preclinical approaches to evaluate the potential of immunosuppressive drugs to influence human neoplasia. Int J Toxicol. 2010 29(5):435-66.
- 2012: Waggie KS, et al. Preclinical safety, pharmacokinetics, and pharmacodynamics of recombinant human interleukin-21 in cynomolgus macaques (Macaca fascicularis). Int J Toxicol. 2012 31(4):303-16.
- 2013: Shah et al. Reduction in the number of animals and the evaluation period for the positive control group in Tg.rasH2 short-term carcinogenicity studies. Int J Toxicol. 2012, 31(5): 423–9.
Participation in the selection of the Best Paper Award is an easy and important way for those ACT members who want to become more involved to do so in a very meaningful way.
I look forward to receiving your suggestions!
Thank you,
Mary Beth Genter, PhD, DABT, Fellow, ATS
Editor-in-Chief
International Journal of Toxicology